iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares LALPATHLAB DR. LAL PATH LABS LTD. INE600L01024 Board Meeting New 2025-07-31 Yes 2025-07-01 2025-08-02 Financial results Dividend Other business Unaudited Standalone And Consolidated Quarterly June 2025 Interim The meeting of the Board of Directors is scheduled to be held on Thursday, July 31, 2025 to inter-alia consider and approve the Un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended June 30, 2025 and to consider recommending Interim Dividend, if any, on the Equity Shares of the Company for the Financial Year 2025-26.